&nbsp;

Dec 2025

Regimen

ALEC

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

Exceptional Access Program

alectinib - Treatment of ALK-positive locally advanced or metastatic non-small cell lung cancer, according to specific criteria

Drugs Used:

alectinib

... Show more tags

Quick Link(s):

Regimen Monograph

Dec 2025

Regimen

ASCI

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

asciminib - For the treatment of Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, based on criteria

Drugs Used:

asciminib

... Show more tags

Quick Link(s):

Regimen Monograph

Dec 2025

Drug

acalabrutinib

Other Name(s): Calquence®

Quick Link(s):

Dec 2025

Drug

abemaciclib

Other Name(s): Verzenio®

Quick Link(s):

Dec 2025

Drug

anastrozole

Other Name(s): Arimidex®

Quick Link(s):

Dec 2025

Regimen

ACAL

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Funding:

Exceptional Access Program

acalabrutinib - For the treatment of adult patients with chronic lymphocytic leukemia (CLL), based on criteria

Drugs Used:

acalabrutinib

... Show more tags

Quick Link(s):

Regimen Monograph

Dec 2025

Regimen

MFOLFOX6

Cancer Type:

Gastrointestinal,

Colorectal,

Rectal

Intent: Neoadjuvant

Drugs Used:

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Jan 2026

Drug

atezolizumab

Other Name(s): Tecentriq™

Quick Link(s):

Jul 2025

Managing Shortness of Breath For People With Cancer

Drug

mogamulizumab

Other Name(s): Poteligeo®

Quick Link(s):

Drug Monograph

May 2024

Regimen

ABVD

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Curative

Drugs Used: